CYLD and nasopharyngeal carcinoma: Recurrent SVs of CYLD, including deletion, tandem duplication, and inversion, were detected and verified in three of the newly established NPC PDXs/cell (Xeno23, 47 and NPC43) (Fig. 8a; Supplementary Fig. 17).